← Back to Search

taVNS for Pupillary Response

N/A

Recruiting

Led By Mario Svirsky, PhD

Research Sponsored by NYU Langone Health

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Healthy individuals 18 to 65

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, month 3

Awards & highlights

Study Summary

This trial will study the effects of a new nerve stimulation therapy on learning and perception.

Who is the study for?

This trial is for healthy individuals aged 18 to 65 with normal hearing. It's not suitable for those with heart muscle diseases, irregular heartbeats, implanted devices like pacemakers or vagal stimulators, metallic implants in their body, or pregnant women.Check my eligibility

What is being tested?

The study is testing the effects of transcutaneous auricular vagal nerve stimulation (taVNS) on how the pupil responds and on learning during a task that requires quick decisions. Participants will be compared across three groups: taVNS, sham (fake) stimulation, and no intervention.See study design

What are the potential side effects?

Possible side effects from taVNS may include discomfort at the stimulation site, headache, lightheadedness or fainting. Sham stimulation should have minimal to no side effects as it's a fake treatment used for comparison.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 18 and 65 years old and healthy.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, month 3

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, month 3

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, month 3 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Overall Mean Peak (Pupillary Response)

Change in Speed of Learning to Perform a Behavioral Task

Change in Time It Takes to Reach 90% of Asymptotic Level Performance

Trial Design

3Treatment groups

Experimental Treatment

Active Control

Placebo Group

Group I: Transcutaneous Auricular Vagal Nerve Stimulation (taVNS)Experimental Treatment1 Intervention

Group II: No Intervention (Control)Active Control1 Intervention

Group III: ShamPlacebo Group1 Intervention

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

NYU Langone HealthLead Sponsor

1,368 Previous Clinical Trials

839,676 Total Patients Enrolled

Mario Svirsky, PhDPrincipal InvestigatorNYU Langone Health

Media Library

Transcutaneous Auricular Vagal Nerve Stimulation (taVNS) Clinical Trial Eligibility Overview. Trial Name: NCT05386563 — N/A

Pupillary Response Research Study Groups: Sham, Transcutaneous Auricular Vagal Nerve Stimulation (taVNS), No Intervention (Control)

Pupillary Response Clinical Trial 2023: Transcutaneous Auricular Vagal Nerve Stimulation (taVNS) Highlights & Side Effects. Trial Name: NCT05386563 — N/A

Transcutaneous Auricular Vagal Nerve Stimulation (taVNS) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05386563 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many people have signed up for this research endeavor?

"Affirmative. The details posted on clinicaltrials.gov signify that recruitment is ongoing for this medical trial, which was initially uploaded to the website on May 18th 2022 and updated lastly on May 24th 2022. A total of 50 participants must be recruited at a single centre."

Answered by AI

Is enrollment open for this clinical experiment?

"Affirmative. Clinicaltrials.gov data indicates that this medical experiment, which was posted on May 18th 2022, is presently enrolling patients. There will be a maximum of 50 individuals admitted from 1 selected research centre."

Answered by AI

Is the upper age limit for participants in this trial above fifty years?

"According to the prerequisites for participation, individuals must be between 18-65 years old in order to qualify."

Answered by AI

Am I eligible to join this experiment?

"This medical study is looking to enrol 50 individuals of 18-65 years who have a satisfactory pupillary reflex. The most important criteria for candidates are: proper health state, being in the age range specified and having normal audiometric test results."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

taVNS on Pupillary Response and Perceptual Learning

2022. "taVNS on Pupillary Response and Perceptual Learning". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05386563.